Patents by Inventor Kirsten Peters

Kirsten Peters has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Identifying an Agent for Treating Abnormal Kidney Function
    Publication number: 20190107546
    Abstract: Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
    Type: Application
    Filed: December 13, 2018
    Publication date: April 11, 2019
    Inventors: Thomas Stoll, Scott Bringans, Kaye Winfield, Tammy Casey, Wendy Davis, Kirsten Peters, Timothy Davis, Richard Lipscombe
  • Method for identifying an agent for treating abnormal kidney function
    Patent number: 10191067
    Abstract: Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
    Type: Grant
    Filed: June 26, 2017
    Date of Patent: January 29, 2019
    Assignee: Proteomics International Pty Ltd
    Inventors: Thomas Stoll, Scott Bringans, Kaye Winfield, Tammy Casey, Wendy Davis, Kirsten Peters, Timothy Davis, Richard Lipscombe
  • Use of CD5 Antigen-Like as a Biomarker for Diabetic Nephropathy
    Publication number: 20170299613
    Abstract: Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
    Type: Application
    Filed: June 26, 2017
    Publication date: October 19, 2017
    Inventors: Thomas Stoll, Scott Bringans, Kaye Winfield, Tammy Casey, Wendy Davis, Kirsten Peters, Timothy Davis, Richard Lipscombe
  • Method of assessing a subject for abnormal kidney function
    Patent number: 9733259
    Abstract: Biomarkers for abnormal kidney function, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV, and methods for their use in assessing abnormal kidney function are disclosed herein.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: August 15, 2017
    Assignees: Proteomics International Pty Ltd, The University of Western Australia
    Inventors: Thomas Stoll, Scott Bringans, Kaye Winfield, Tammy Casey, Wendy Davis, Kirsten Peters, Timothy Davis, Richard Lipscombe
  • Use of CD5 Antigen-Like as a Biomarker for Diabetic Nephropathy
    Publication number: 20150355198
    Abstract: Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
    Type: Application
    Filed: August 24, 2015
    Publication date: December 10, 2015
    Inventors: Thomas Stoll, Scott Bringans, Kaye Winfield, Tammy Casey, Wendy Davis, Kirsten Peters, Timothy Davis, Richard Lipscombe
  • Method of assessing diabetic nephropathy using CD5 antigen-like
    Patent number: 9146243
    Abstract: Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
    Type: Grant
    Filed: May 14, 2014
    Date of Patent: September 29, 2015
    Assignees: Proteomics International Pty Ltd, The University of Western Australia
    Inventors: Thomas Stoll, Scott Bringans, Kaye Winfield, Tammy Casey, Wendy Davis, Kirsten Peters, Timothy Davis, Richard Lipscombe
  • USE OF CD5 ANTIGEN-LIKE AS A BIOMARKER FOR DIABETIC NEPHROPATHY
    Publication number: 20140249049
    Abstract: Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
    Type: Application
    Filed: May 14, 2014
    Publication date: September 4, 2014
    Applicants: PROTEOMICS INTERNATIONAL PTY LTD, THE UNIVERSITY OF WESTERN AUSTRALIA
    Inventors: Thomas STOLL, Scott BRINGANS, Kaye WINFIELD, Tammy CASEY, Wendy DAVIS, Kirsten PETERS, Timothy DAVIS, Richard LIPSCOMBE
  • BIOMARKERS ASSOCIATED WITH PRE-DIABETES, DIABETES AND DIABETES RELATED CONDITIONS
    Publication number: 20130177544
    Abstract: Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
    Type: Application
    Filed: September 20, 2011
    Publication date: July 11, 2013
    Applicants: THE UNIVERSITY OF WESTERN AUSTRALIA, PROTEOMICS INTERNATIONAL PTY LTD
    Inventors: Thomas Stoll, Scott Bringans, Kaye Winfield, Tammy Casey, Wendy Davis, Kirsten Peters, Timothy Davis, Richard Lipscombe
  • Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties
    Patent number: 7452910
    Abstract: The invention relates to the use of N-substituted indole-3-glyoxylamides of the general Formula I: and to pharmaceutical compositions having antitumor action.
    Type: Grant
    Filed: October 17, 2003
    Date of Patent: November 18, 2008
    Assignee: ZIOPHARM Oncology, Inc.
    Inventors: Bernd Nickel, Gerald Bacher, Thomas Klenner, Thomas Beckers, Peter Emig, Jürgen Engel, Erik Bruyneel, Günter Kamp, Kirsten Peters
  • Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties
    Publication number: 20080057124
    Abstract: The invention relates to the use of N-substituted indole-3-glyoxylamides of the general and to pharmaceutical compositions having antitumor action.
    Type: Application
    Filed: August 20, 2007
    Publication date: March 6, 2008
    Inventors: Bernd Nickel, Gerald Bacher, Thomas Klenner, Thomas Beckers, Peter Emig, Jurgen Engel, Erik Bruyneel, Gunter Kamp, Kirsten Peters
  • Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties
    Publication number: 20040171668
    Abstract: The invention relates to the use of N-substituted indole-3-glyoxylamides of the general Formula I: 1
    Type: Application
    Filed: October 17, 2003
    Publication date: September 2, 2004
    Applicant: Baxter Healthcare SA
    Inventors: Bernd Nickel, Gerald Bacher, Thomas Klenner, Thomas Beckers, Peter Emig, Jurgen Engel, Erik Bruyneel, Gunter Kamp, Kirsten Peters
  • Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties
    Patent number: 6693119
    Abstract: The invention relates to the use of N-substituted indole-3-glyoxylamides of the general Formula I and to pharmaceutical compositions having antitumor action.
    Type: Grant
    Filed: January 27, 2000
    Date of Patent: February 17, 2004
    Assignee: Baxter Healthcare SA
    Inventors: Bernd Nickel, Gerald Bacher, Thomas Klenner, Thomas Beckers, Peter Emig, Jürgen Engel, Erik Bruyneel, Günter Kamp, Kirsten Peters
  • Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties
    Publication number: 20030114511
    Abstract: The object of the invention is then to widen the field of use of N-substituted indole-3-glyoxylamides and thus to enrich the available pharmaceutical wealth. The possibility of a lower, longer-lasting and better-tolerable medication for the class of substances having antitumor action described in German Patent Application 19814 838.0 should thus be opened up. In particular, the disadvantageous development of resistance, as is known of many antitumor agents, should be circumvented.
    Type: Application
    Filed: January 27, 2000
    Publication date: June 19, 2003
    Inventors: Bernd Nickel, Gerald Bacher, Thomas Klenner, Thomas Beckers, Peter Emig, Jurgen Engel, Erik Bruyneel, Gunter Kamp, Kirsten Peters